Back to User profile » Dr Na Zhao

Papers published by Dr Na Zhao:


Venetoclax Plus Hypomethylating Agents for Treatment-Naïve Myelodysplastic Syndromes with Increased Blasts: A Prospective Multicenter Cohort Study

Zhao N, Zhu L, Hu X, Tong J, Ge H, Ye L, Zhu X, Gai C, Feng Y, Zhang L, Wang L, Sun G, Xue L, Zhu X, Zheng C

Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:592550

Published Date: 24 April 2026

Selinexor Synergistically Promotes the Antileukemia Activity of Venetoclax in Acute Myeloid Leukemia by Inhibiting Glycolytic Function and Downregulating the Expression of DNA Replication Genes

Jiang J, Wang Y, Liu D, Wang X, Zhu Y, Tong J, Chen E, Xue L, Zhao N, Liang T, Zheng C

ImmunoTargets and Therapy 2023, 12:135-147

Published Date: 23 November 2023

Standard-Intensity Induction and Intermediate/High-Dose Cytarabine Consolidation Can Improve Survival for Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia: A Retrospective Cohort Study

Wang L, Zhao N, Zhou L, Tong J, Xue L, Zhang L, Han Y, Wang X, Geng L, Tang B, Liu H, Zhu W, Cai X, Liu X, Zhu X, Sun Z, Zheng C

Clinical Interventions in Aging 2022, 17:55-64

Published Date: 20 January 2022

Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting

Tong J, Zhao N, Hu X, Yao W, Cheng Y, Zhou L, Liu H, Geng L, Sun Z, Zheng C

Cancer Management and Research 2021, 13:5613-5621

Published Date: 12 July 2021

Imbalance of T Lymphocyte Subsets in Adult Immune Thrombocytopenia

Lin X, Xu A, Zhou L, Zhao N, Zhang X, Xu J, Feng S, Zheng C

International Journal of General Medicine 2021, 14:937-947

Published Date: 18 March 2021

Urgent Chemotherapy Successfully Rescues a Near Death Patient of Acute Intracranial Hypertension Caused by Intracranial Myeloid Sarcoma

Zhou L, Zhang X, Feng S, Zhao N, Hu X, Huang L, Zheng C

OncoTargets and Therapy 2020, 13:237-241

Published Date: 9 January 2020